Biotech and Pharmaceuticals

However, Biden said the U.S. currently has enough vaccine supply to ensure people ages 50 and older can get their fourth doses.

President Joe Biden will give an update on the U.S. fight against Covid-19 and receive his second vaccine booster shot.

Dr. Peter Marks said the U.S. might need to switch to a different vaccine that targets specific variants of Covid.

The more contagious omicron subvariant, BA.2, is now the dominant version of Covid in the U.S., at nearly 55% of sequenced Covid cases, according to the CDC.

The CDC and FDA made the decision without consulting their committees of independent vaccine experts.

“You have people that are younger adults that have comorbidity factors, and they might need [a] sooner fourth dose to protect them,” CEO Stephane Bancel told CNBC.

Singapore will ease most of its Covid restrictions including outdoor mask mandates from next week, Prime Minister Lee Hsien Loong announced on Thursday.

Data from Walgreens, which conducts testing at its pharmacies nationwide, shows BA.2 as the dominant variant at 51% of all positive Covid cases as of March 19.

The rise in cases across the continent is being driven by several causes including the spread of the omicron subvariant, BA.2.

Moderna also asked the FDA to authorize its vaccine for children 6- to 11-years-old, the company announced Wednesday.

AstraZeneca has taken a roughly £25 million ($33 million) stake in U.K. health start-up Huma, according to a person familiar with the matter.

Venture capitalist Ambar Bhattacharyya on digital health investment trends and predictions for 2022.

Pfizer expects to start supplying the antiviral pills, Paxlovid, to UNICEF beginning next month and will continue to do so through the end of the year.

An FDA advisory committee will discuss Covid-19 boosters for the coming months and what factors would make it necessary to update the shots to target specific variants.

Investors see growth opportunity in Femtech as more employers adopt coverage for women’s health services and technology

It’s been two years since Covid-19 crept across the globe, battered the U.S. economy and wreaked havoc on health-care systems unprepared to defend themselves against the novel pathogen. Now, as the latest wave of infections driven by the fast-spreading omicron variant rapidly subsides, many are beginning to question: Is Covid-19 becoming endemic? “There’s a high probability we’re moving into...

Pfizer CEO Albert Bourla received $24.3 million in total compensation for 2021, a 15% increase over the prior year.

Martin Shkreli lost the civil case involving the drug Daraprim while serving a criminal sentence for unrelated securities fraud.

Merck plans to submit the data on early stage lung cancer to the FDA as soon as possible.

Jha leads Brown University’s School of Public Health and previously headed Harvard’s Global Health Institute.